BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baribeau D, Anagnostou E. Novel treatments for autism spectrum disorder based on genomics and systems biology. Pharmacol Ther 2021;:107939. [PMID: 34174273 DOI: 10.1016/j.pharmthera.2021.107939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 El-Sayed A, Aleya L, Kamel M. Microbiota and epigenetics: promising therapeutic approaches? Environ Sci Pollut Res Int 2021. [PMID: 34319520 DOI: 10.1007/s11356-021-15623-6] [Reference Citation Analysis]
2 Lin X, Liang Y, Herrera-Molina R, Montag D. Neuroplastin in Neuropsychiatric Diseases. Genes (Basel) 2021;12:1507. [PMID: 34680901 DOI: 10.3390/genes12101507] [Reference Citation Analysis]
3 Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism 2022;13:10. [PMID: 35246237 DOI: 10.1186/s13229-022-00488-4] [Reference Citation Analysis]